Sleep Problems: Report

Embed Size (px)

Citation preview

  • 7/29/2019 Sleep Problems: Report

    1/3

    Narcolepsy is a relatively common but unknown sleep disorder that has many symptoms, including

    excessive sleepiness and automatic sleep attacks. Afflicted may have strange sleep schedules and

    intruding feelings of drowsiness throughout the day, even after an adequate amount of sleep. These

    individuals are also typically able to fall into the REM stage of sleep much quicker than the averagepopulation.

    Many individuals that suffer from narcolepsy also have another disease called cataplexy.

    Cataplexy is defined as the sudden loss of muscle tone. This sudden loss is often triggered by strongemotions like laughing or crying. The weakness of muscle ranges anywhere from a small loosening of

    the facial muscles to a full collapse. While those with cataplexy could potentially fall asleep during

    these attacks, those episodes of sleep are not related to narcoleptic ones.There are many tests to see if one has narcolepsy. The most used test is the Multiple Sleep

    Latency Test (MSLT). In this test, the patient sleeps in increments of 20 minutes with two hours

    between each sleep event. Data is monitored during this test, including brain waves, eye movements,and brain activity. Periodically, it is difficult to discern if a patient has narcolepsy or not from the

    MSLT. In this case, it is more wise to do a repeat (or repeats, if needed) than to attempt other tests, as

    they are not nearly as accurate. In a study by the University of Toronto, Canada, it was discovered that

    just a single repeat MSLT would confirm a diagnosis of narcolepsy that a first test had not completelyconfirmed.

    Another common test is the polysomnogram, which is a recording of brain waves as well as

    muscle and nerve functions taken while the patient is asleep. It can quickly confirm if a patient hasentered REM, which, depending on how long it takes to get to the REM stage, can be a good indicator

    on whether or not the patient has narcolepsy.

    Recent studies have uncovered a link between narcolepsy and to a produced protein calledhypocretin. Hypocretin, also called orexin, is responsible for managing sleep patterns. Sufferers are

    usually found to have less of the neurons that produce this protein. When hypocretin levels are low,

    sleep balance is hard to maintain and people may face irregular sleep patterns. This is simply because

    there are too little hypocretin proteins to properly keep the schedule intact.Another, more recent, study suggests that there may be a link with the influenza virus,

    specifically H1N1. There was a large increase in the number of narcoleptic children in Finland

    following the H1N1 scare of 2009. In 2010, 54 children were diagnosed with narcolepsy. Out of these54, 50 of them had been vaccinated up to 242 days before symptoms began showing. They had been

    vaccinated by a popular H1N1 vaccination at the time.

    In China, also at the same time, was a growth of the number of narcoleptics. This group isdifferent from the Finland group in that only a few had gone in for a vaccination. Out of 142 patients

    that had developed narcolepsy, only eight had received an H1N1 vaccination. This is explained by the

    fact that many of these Chinese had been victims of H1N1 previously. The onset of narcolepsy hadpositively correlated with the H1N1 infection (as well as other, lesser known upper airway infections).

    The other large link between H1N1 and narcolepsy is one of the respiratory system. Any upper

    airway infection, which includes H1N1, has been shown to lead to a immune response that will cause

    the brain to lose hypocretin-producing neurons. Following this, it is also believed that breathingproblems that narcoleptics have are linked to a hypocretin deficiency.

    Narcolepsy can not only introduce, but also tend to, other sleep-related problems. Narcoleptics

    commonly suffer from sleep paralysis, which is when the body is asleep but the mind is awake.Typically, sufferers are fully aware of their surroundings and are conscious, but their bodies are unable

    to move. These episodes can last anywhere from seconds to hours and can be extremely frightening to

    those that experience them. Narcoleptics are also able to have more believable dreams. For many,hallucinations are a normal part of life simply because dreams and the real world are difficult to

    distinguish. Many narcoleptics can use all of their senses in dreams similar to how they could be used

    in real life. For example, smelling a flower would not just evoke a similar smell and emotion like it

  • 7/29/2019 Sleep Problems: Report

    2/3

    would to a normal person. Smelling a flower would be the full experience of doing so in real life to a

    narcoleptic, complete with the smell and physical feelings that smelling something would introduce.

    Physically, there are other problems that can be serious to narcoleptics. There is a large

    correlation between having narcolepsy and having some sort of sleep-disordered breathing problem.Since there are studies that show a link between upper airway problems and narcolepsy, it is easy to see

    the parallel between two of these disorders. Out of 102 narcoleptics, 29 were sufferers of an obstructive

    sleep breathing disorder.This disease is one that, if not properly attended to, can lead to serious problems, not only

    physically, but mentally as well. Narcolepsy typically appears during adolescence, which is a difficult

    time for many people. Common side effects to narcoleptics include seemingly uncontrollable weightgain, social difficulties, irritability, frustration, and overall difficulties in concentration. Due to these

    problems, many afflicted adolescents turn to substance use. Many use illegal substances just to keep

    them awake, unaware of the problems associated with them. Recently, though, there has been evidenceto support that nicotine may somehow lower the incidence of sleep attacks or other narcoleptic

    episodes.

    Recent work has introduced the role of hypocretin in drug addiction. Hypocretin could have a

    link to quite a few aspects of addiction, including reinstatement and dependence. Hypocretin couldquite possibly influence the states that influence addiction, which could help explain why so many

    narcoleptics turn to drugs in the first place. Even so, it is difficult to tell exactly how much of an

    influence hypocretin has on drug addiction to a narcoleptic, especially with the amount of hypocretinbeing so small compared to a healthy person.

    Narcoleptic social difficulties can be destructive to a personality, since they, on average, face a

    harsher world than the unaffected. Narcoleptics have higher health-related costs (including doctor visitsand insurance costs), a higher chance of dabbling in medications, and an overall higher cost of living.

    They also have to deal with lower employment rates, lower income, and less actual on-the-job hours.

    These problems can exist long before a narcoleptic is actually ever diagnosed. According to one study,

    these consequences had been found 11 years prior to the first diagnosis. The situations only worsenedor became more prevalent as time went on.

    There are only a limited number of treatments available, and the majority of these do not target

    the problem directly. Most are just stimulants that activate the transmission of dopamine in the brain.Anti-depressant medication and therapies are also effective in the treatment of symptoms, as the

    constant transmission of adrenaline keeps users awake and alert to the point where sleep attacks and

    drowsiness episodes are much less likely to happen. Behavioral and schedule therapies are alsocommon approaches to helping the problem, and, much of the time, are paired together. Trying to do

    studies in aversive conditioning showed disheartening results. Unmedicated narcolepsy patients had no

    response in the amygdala to the conditioned stimuli.More recently, studies in using GHB (Gamma-hydroxybutyrate) to treat symptoms have

    happened. These studies show that using GHB is a decent treatment for sleep attacks, but not for other

    symptoms. Daytime sleepiness and sleep attacks were removed for many sufferers, but overall sleep

    times, length of night sleeping, and length of sleep cycles had no changes. A barrier to treatment is thefact adult and child research does not have much in common. Since children are still developing, brains

    are tougher to gauge in their possible potential. As far as the future holds, hypocretin replacement is a

    very popular therapy idea that could have the potential to cure most, if not all, problems related to thisdisease.

    Works Cited

    DiLeone, R., Sarhan, M., and Sharf, R. 2011. Orexin/Hypocretin, Drug Addiction, and Narcolepsy.

  • 7/29/2019 Sleep Problems: Report

    3/3

    Narcolepsy. Springer New York; New York, NY. Pg. 253-260

    Weinhold, Sara Lena, Mareen Seeck-Hirschner, Alexander Nowak, Robert Gder, and Paul Christian

    Baier. 2011. "Wake-REM sleep transitions for measuring REM sleep disturbance: Comparison betweennarcolepsy, idiopathic hypersomnia and healthy controls." Sleep & Biological Rhythms 9, no. 3: 172-

    177.Academic Search Premier.

    Kornum, Birgitte Rahbek, Juliette Faraco, and Emmanuel Mignot. 2011. "Narcolepsy with

    hypocretin/orexin deficiency, infections and autoimmunity of the brain." Current Opinion In

    Neurobiology 21, no. 6: 897-903.Academic Search Premier, EBSCOhost.

    HAN, FANG. 2012. "Sleepiness that cannot be overcome: Narcolepsy and cataplexy."Respirology 17,

    no. 8: 1157-1165.Academic Search Premier, EBSCOhost.

    Sullivan, Shannon S. 2010. "Narcolepsy in adolescents."Adolescent Medicine: State Of The Art

    Reviews 21, no. 3: 542.MEDLINE, EBSCOhost.

    Viorritto, Erick N, Suraiya A Kureshi, and Judith A Owens. 2012. "Narcolepsy in the pediatric

    population." Current Neurology And Neuroscience Reports 12, no. 2: 175-181.MEDLINE.

    Ritchie, Cayde, Masashi Okuro, Takashi Kanbayashi, and Seiji Nishino. 2010. "Hypocretin ligand

    deficiency in narcolepsy: recent basic and clinical insights." Current Neurology And Neuroscience

    Reports 10, no. 3: 180-189.MEDLINE.

    Partinen, Markku, Outi Saarenp-Heikkila, Ismo Ilveskoski, Christer Hublin, Miika Linna, Pivi

    Olsn, and Turkka Kirjavainen, et al. 2012. "Increased Incidence and Clinical Picture of Childhood

    Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland."Plos ONE7, no. 3:1-9.Academic Search Premier, EBSCOhost.

    Ozaki, Akiko, Yuichi Inoue, Kenichi Hayashida, Toru Nakajima, Makoto Honda, Akira Usui, YokoKomada, Mina Kobayashi, and Kiyohisa Takahashi. 2012. "Quality of life in patients with narcolepsy

    with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time:

    comparison between patients on psychostimulants, drug-nave patients and the general Japanesepopulation." Sleep Medicine 13, no. 2: 200-206.MEDLINE.

    Ebben, Matthew R, and Ana C Krieger. 2012. "Narcolepsy with cataplexy masked by the use ofnicotine."Journal Of Clinical Sleep Medicine: JCSM: Official Publication Of The American AcademyOf Sleep Medicine 8, no. 2: 195-196.MEDLINE, EBSCOhost.

    Nishino, S., M. Okuro, N. Kotorii, E. Anegawa, Y. Ishimaru, M. Matsumura, and T. Kanbayashi. 2010."Hypocretin/orexin and narcolepsy: new basic and clinical insights."Acta Physiologica 198, no. 3:

    209-222.Academic Search Premier, EBSCOhost.

    Pataka, A D, R R Frangulyan, T W Mackay, N J Douglas, and R L Riha. 2012. "Narcolepsy and sleep-

    disordered breathing." European Journal Of Neurology: The Official Journal Of The European

    Federation Of Neurological Societies 19, no. 5: 696-702. MEDLINE, EBSCOhost.